Preventing VTE in Outpatients With Cancer.
James P. Wilmot Cancer Center and Department of Medicine, University of Rochester, Rochester, NY. Electronic address: alok_khorana@urmc.rochester.edu.
Alok A
AA
Khorana
James P. Wilmot Cancer Center and Department of Medicine, University of Rochester, Rochester, NY.
Alex C
AC
Spyropoulos
Division of Hemostasis-Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Jeffrey
J
Zwicker
Duke University and Duke Cancer Institute, Durham, NC.
Gary H
GH
Lyman
James P. Wilmot Cancer Center and Department of Medicine, University of Rochester, Rochester, NY.
Charles W
CW
Francis
D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D012955:Societies, Medical; D054556:Venous Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control*
D005343:Fibrinolytic Agents